Nebupent Related Published Studies
Well-designed clinical trials related to Nebupent (Pentamidine)
Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii
in acquired immune deficiency syndrome. [1995]
A randomized comparison of once-monthly or twice-monthly high-dose aerosolized
pentamidine prophylaxis. [1993]
Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS
patients: results of a blinded dose-comparison study using an ultrasonic
nebulizer. [1991]
Well-designed clinical trials possibly related to Nebupent (Pentamidine)
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic
HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind
placebo-controlled trial. [1995]
Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients
with advanced human immunodeficiency virus disease: results of a randomized
trial. Terry Beirn Community Programs for Clinical Research on AIDS. [1994]
Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat
Pneumocystis carinii pneumonia in patients with AIDS. [1993]
Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of
urinary tract infection in renal transplant recipients. A double-blind,
randomized controlled trial. [1992]
Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency
syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus
trimethoprim-dapsone. [1990]
Other research related to Nebupent (Pentamidine)
Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous
leishmaniasis. [2005]
A randomized clinical trial of low dosage combination of pentamidine and
allopurinol in the treatment of antimony unresponsive cases of visceral
leishmaniasis. [2001]
Atovaquone suspension compared with aerosolized pentamidine for prevention of
Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects
intolerant of trimethoprim or sulfonamides. [1999]
Long-term administration of aerosolized pentamidine as primary prophylaxis
against Pneumocystis carinii pneumonia in infants and children with symptomatic
human immunodeficiency virus infection. The Italian Pediatric Collaborative Study
Group on Pentamidine. [1996]
Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary
prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a
two-year Italian multicentric randomized controlled trial. The Italian PCP Study
Group. [1996]
Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for
prophylaxis of pneumocystis carinii pneumonia in patients infected with the human
immunodeficiency virus. [1995]
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary
prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. [1995]
Better efficacy of twice-monthly than monthly aerosolised pentamidine for
secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. An
Italian multicentric randomised controlled trial. The Italian PCP Study Group. [1995]
Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. [1995]
Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii
pneumonia in patients with AIDS. Atovaquone Study Group. [1994]
Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of
Pneumocystis carinii pneumonia and toxoplasmic encephalitis. [1993]
Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in
Colombia. [1993]
Other possibly related research studies
Chemotherapy for second-stage Human African trypanosomiasis. [2010]
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with
HIV-infection. [2006]
Treatment options for visceral leishmaniasis: a systematic review of clinical
studies done in India, 1980-2004. [2005]
Treatment of canine Old World visceral leishmaniasis: a systematic review. [2005]
QT prolongation with antimicrobial agents: understanding the significance. [2004]
Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial
infections in a randomized prophylaxis trial of patients with advanced HIV
infection. [2002]
[Cerebral toxoplasmosis in HIV infected patients intolerant of cotrimoxazole]. [Article in French] [1998]
Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial
with inverse probability of censoring weighted (IPCW) log-rank tests. [2000]
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and
toxoplasmic encephalitis in human immunodeficiency virus type I-infected
patients: the changes in opportunistic prophylaxis study. [2000]
Combining mortality and longitudinal measures in clinical trials. [1999]
Heterogeneity of the baseline risk within patient populations of clinical trials:
a proposed evaluation algorithm. [1998]
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia
and toxoplasma encephalitis in HIV-infected patients. [1997]
A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii
prophylactic regimens. [1996]
Validating literature-based models with direct clinical trial results: the
cost-effectiveness of secondary prophylaxis for PCP in AIDS patients. [1996]
AIDS-related spontaneous pneumothorax. Risk factors and treatment. [1995]
A randomized trial of three antipneumocystis agents in patients with advanced
human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. [1995]
The role of atovaquone tablets in treating Pneumocystis carinii pneumonia. [1995]
Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by
roxithromycin in HIV-infected patients. [1995]
Limited efficacy of injectable aminosidine as single-agent therapy for Colombian
cutaneous leishmaniasis. [1994]
Are incremental doses of amphotericin B required for the treatment of visceral
leishmaniasis? [1994]
[Current therapy of trypanosomiasis] [1994]
Chemotherapy for second-stage human African trypanosomiasis. [2013]
Interventions for American cutaneous and mucocutaneous leishmaniasis: a
systematic review update. [2013]
|